HPLC

Optimi Health Granted Precursor Licence To Formulate MDMA And Completes Encapsulation Of 40mg And 60mg Dosage Formats

Retrieved on: 
Wednesday, January 3, 2024
Physician, MAPS, FDA, FRA, NDA, MDMA, GMP, New Drug Application, Chromatography, American Medical Association, COA, Health Canada, HPLC, Safety, MDP2P, Pharmaceutical industry

"Securing our precursor licence represents a pivotal advantage for Optimi, offering a compelling edge in producing MDMA at significantly reduced costs," said Optimi Chief Financial Officer Jacob Safarik.

Key Points: 
  • "Securing our precursor licence represents a pivotal advantage for Optimi, offering a compelling edge in producing MDMA at significantly reduced costs," said Optimi Chief Financial Officer Jacob Safarik.
  • "With the AMA’s current procedural terminology ("CPT") III codes for psychedelic-assisted therapies now officially in effect, this underscores the goal of obtaining our precursor licence.
  • With the Company’s precursor licence secured, Optimi Chief Science Officer, Dr. Preston A.
  • Chase, is pleased to report the successful encapsulation of MDMA into 40mg and 60mg dosage formats after verification through its High-performance Liquid Chromatography (HPLC) methodology.

Astrotech Presents the First Process Control System for Cannabinoid Oil Distillation Systems

Retrieved on: 
Tuesday, November 28, 2023
MDS, Temperature, ASTC, Feedback, IBN, Las Vegas Convention Center, HPLC, Pressure, Video game

This process is a revolutionary process control system proven to increase the potency of ending-weight yields and increase revenue by an average of 32%.

Key Points: 
  • This process is a revolutionary process control system proven to increase the potency of ending-weight yields and increase revenue by an average of 32%.
  • MVPTM is the fastest and most accurate testing method available, providing up to 20 tests per hour and ensuring optimal continuous processing.
  • MVPTM is compatible with any of the thin-film, short-path, Molecular Distillation Systems (MDS) operating under high vacuum.
  • We believe this is a game changer for the cannabinoid industry and that all cannabinoid processors will need AgLAB MVPTM to stay competitive,” said Tom Pickens, CEO/CTO of Astrotech.

Agilent Again Named “Global Lighthouse” by World Economic Forum for Manufacturing Innovations

Retrieved on: 
Thursday, December 14, 2023
Technology, Manufacturing, IOT (Internet of Things), Professional Services, Robotics, Other Manufacturing, Data Analytics, Software, Artificial Intelligence, Machine Tools, Metalworking & Metallurgy, Chemicals, Plastics, Computer, Industrial internet of things, NYSE, Steam, OFS, HPLC, Multimedia, Agilent Technologies, Artificial intelligence, Machine learning, Quality control, Automation, Fourth Industrial Revolution, Internet, McKinsey & Company, Industrial Revolution, Lighthouse, Electricity, WEF, 3D printing, Fine chemical, Waldbronn

Agilent Technologies Inc. (NYSE: A) today announced the company’s manufacturing facility in Waldbronn, Germany, has been named a Global Lighthouse by the World Economic Forum (WEF) for innovations that boost productivity, output, and quality.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced the company’s manufacturing facility in Waldbronn, Germany, has been named a Global Lighthouse by the World Economic Forum (WEF) for innovations that boost productivity, output, and quality.
  • Only 153 manufacturing facilities worldwide have received the Lighthouse distinction from WEF, and Agilent is the sole analytical and clinical laboratory technology company among them.
  • It is the second Agilent facility to be named a Lighthouse, after Agilent’s Singapore site in 2022 .
  • To earn the Lighthouse designation, the Agilent team rapidly developed, piloted, and scaled smart manufacturing technologies while navigating a period of unprecedented demand and supply chain disruption.

Glycomics Market Size, Share & Trends Analysis Report 2023: Enzymes, Kits, Reagents, Instruments, Drug Discovery & Development, Diagnostics - Global Market to Reach $4.92 Billion by 2030 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023
Biotechnology, Pharmaceutical, Health, Biometrics, Medicine, Research, National Cancer Institute, HPLC, Informatics, Enzyme, CE, Capillary electrophoresis, Drug discovery, Mass spectrometry, Glycomics, Biomarker, Pharmaceutical industry, Diagnosis

Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market.

Key Points: 
  • Growing research and development in the glycomics space, owing to its crucial role in various biological processes, is projected to drive the global market.
  • Moreover, the increasing demand for personalized medicine has further supported industry growth as glycomics plays a significant role in developing glycan-based diagnostic solutions.
  • Recently glycomics have shown promise in identifying disease-specific glycan biomarkers for early detection and diagnosis of various health conditions.
  • For instance, in November 2021 GlycoPath Inc. launched its glycan imaging kit for glycoproteomic analysis of clinical and research samples.

Global Hemoglobin A1C (HbA1C) Testing Strategic Research Report 2023: Market to Reach $2.3 Billion by 2030 from $1.4 Billion in 2022 - Benefits of POC HbA1c Tests Over Lab Tests Drives Adoption - ResearchAndMarkets.com

Retrieved on: 
Friday, December 8, 2023
Medical Devices, Health, Glycated hemoglobin, POC, HPLC, American Diabetes Association, HB, Growth, COVID-19, Medical laboratory, Immunoassay, High-performance liquid chromatography, Diabetes, Pharmaceutical industry

The "Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hemoglobin A1C (HbA1C) Testing - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
  • The report discusses the impact of the COVID-19 pandemic on the utilization of Hemoglobin A1C (HbA1C) laboratory tests, highlighting a new challenge of underutilization.
  • It also provides insights into the competition within the HbA1C testing market, including the global key competitors' percentage market share in 2022.
  • The global market analysis and prospects for HbA1C testing are presented, with a focus on rapid growth in the world HbA1C testing market.

Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution

Retrieved on: 
Thursday, December 7, 2023
Other Health, Radiology, Research, Pharmaceutical, Optical, Oncology, Mental Health, Medical Devices, Infectious Diseases, Hospitals, Fitness & Nutrition, Dental, Clinical Trials, Cardiology, Stem Cells, Science, Biotechnology, Practice Management, Alternative Medicine, Nursing, AIDS, Managed Care, Medical Supplies, Health, FDA, Diabetes, Peptide, HPLC, Multimedia, Pyrosequencing, Workflow, Automation, Drug discovery, Partnership, Fine chemical

Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing high-quality purification and sample preparation solutions, today announced a partnership to offer Biotage® PeptiPEC, based on Gyros’ PurePep® EasyClean (PEC™) catch and release technology, on Biotage® Extrahera™ automated sample preparation system.

Key Points: 
  • Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, and Biotage, a global life sciences company, providing high-quality purification and sample preparation solutions, today announced a partnership to offer Biotage® PeptiPEC, based on Gyros’ PurePep® EasyClean (PEC™) catch and release technology, on Biotage® Extrahera™ automated sample preparation system.
  • The development of an automated plate-based peptide purification workflow provides a fast and environmentally sustainable solution for high-throughput peptide purification.
  • Parallel peptide synthesis generates crude peptide samples at a rate that surpasses the capacity of HPLC, the most common method of peptide purification, which is particularly evident when purifying more than 24 peptides simultaneously.
  • Tomas Blomquist, CEO, Biotage, said: “We’re excited to be partnering with Gyros Protein Technologies to bring a plate-based automated solution for parallel high-throughput peptide purification to market, removing bottlenecks for peptide scientists, and providing a complete workflow solution from synthesis to evaporation.

PFAS Testing Market Worth $121 Million | MarketsandMarkets

Retrieved on: 
Monday, December 11, 2023
Waters Corporation, PFAS, Privatization, HPLC, Research, PerkinElmer, Drinking water, Service, Pollution, Pulse, R, Growth, Agilent Technologies, Shimadzu, Merck Group, Cosmetics, Marketing

Key Market Players of PFAS Testing Industry:

Key Points: 
  • Key Market Players of PFAS Testing Industry:
    As of 2022, prominent players in PFAS testing are Merck KGaA (Germany), Agilent Technologies (US), LGC Limited (UK), Waters Corporation (US), Biotage (Sweden), AccuStandard, Inc. (US), PerkinElmer, Inc. (US), Thermo Fisher Scientific, Inc. (US), Phenomenex (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and Shimadzu Corporation (Japan), among others.
  • In June 2022, MACHEREY-NAGEL GmbH & Co. KG introduced NUCLEODUR PFAS and PFAS Delay, HPLC columns for the analysis of per- and polyfluoroalkyl substances (PFAS).
  • PFAS Testing Market - Key Benefits of Buying the Report:
    The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share.
  • Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

PFAS Testing Market Worth $121 Million | MarketsandMarkets

Retrieved on: 
Monday, December 11, 2023
Waters Corporation, PFAS, Privatization, HPLC, Research, PerkinElmer, Drinking water, Service, Pollution, Pulse, R, Growth, Agilent Technologies, Shimadzu, Merck Group, Cosmetics, Marketing

Key Market Players of PFAS Testing Industry:

Key Points: 
  • Key Market Players of PFAS Testing Industry:
    As of 2022, prominent players in PFAS testing are Merck KGaA (Germany), Agilent Technologies (US), LGC Limited (UK), Waters Corporation (US), Biotage (Sweden), AccuStandard, Inc. (US), PerkinElmer, Inc. (US), Thermo Fisher Scientific, Inc. (US), Phenomenex (US), MACHEREY-NAGEL GmbH & Co. KG (Germany), and Shimadzu Corporation (Japan), among others.
  • In June 2022, MACHEREY-NAGEL GmbH & Co. KG introduced NUCLEODUR PFAS and PFAS Delay, HPLC columns for the analysis of per- and polyfluoroalkyl substances (PFAS).
  • PFAS Testing Market - Key Benefits of Buying the Report:
    The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share.
  • Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.

Calibre Scientific Acquires CPS Analitica, a Provider of Chromatography Consumables in Italy

Retrieved on: 
Monday, October 30, 2023
HPLC, Acquisition, Geography, CPS, GC, Chromatography, Fine chemical

LOS ANGELES, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of C.P.S.

Key Points: 
  • LOS ANGELES, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of C.P.S.
  • (“CPS” or the “Company”), an Italian provider of chromatography consumables for the pharmaceutical, biotech, life sciences, academic, food & beverage, environmental and chemical industries.
  • CPS is Calibre Scientific’s first acquisition in Italy, further expanding its presence in Europe and bolstering its overall product portfolio in the chromatography space.
  • We are excited to welcome CPS Analitica to the Calibre Scientific family.”
    “We are delighted to join Calibre Scientific,” said Roberto Miglio, Managing Director of CPS.

Silanna UV to Demo Innovative UV-C LED Water Quality Sensors at AQUATECH 2023

Retrieved on: 
Thursday, October 19, 2023
Minnesota Department of Natural Resources, Nitrite, Water supply, RAI Amsterdam Convention Centre, Nitrate, Water, HPLC, System, COD, Pesticide, Booth, SF1, Human, PPM, Organization, FWHM, Disinfectant, LED, Drinking water, Ultraviolet, Minnesota Department of Health, EPA, Herbicide, Fertilizer, Fused quartz, Sewage treatment, Nitrogen

BRISBANE, Australia, Oct. 19, 2023 /PRNewswire/ -- Silanna UV will demonstrate innovative new technology for detection of nitrates and organic compounds in water at AQUATECH Amsterdam from November 6 to 9, 2023. Contamination of water by nitrates and organic compounds is a growing problem, and regulations to protect the public from this threat are increasingly stringent.

Key Points: 
  • At AQUATECH, Silanna UV will showcase its SF1 series of Ultraviolet LEDs, which are ideal for water purity applications such as nitrate detection, organic compound detection, disinfection, and HPLC chromatography.
  • Silanna UV is a pioneer in developing patented UV LED technology for shorter wavelengths, from 230nm to 265nm, including deep UV-C and far UV-C ranges.
  • At AQUATECH Silanna UV will demonstrate its nitrate-sensing reference design, which uses the 235nm SF1-3U8P3L1 UV LED emitter in a parabolic lens package that produces a quasi-collimated far UV-C beam.
  • Silanna UV invites all visitors to its booth to learn more about its innovative deep UV-C LED and far UV-C LED solutions for water applications and more.